Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mary Naam
Thyroid Dysfunction in Patients Treated With Sunitinib or Sorafenib
Clinical Genitourinary Cancer
Oncology
Urology
Related publications
Hypothyroidism Side Effect in Patients Treated With Sunitinib or Sorafenib: Clinical and Structural Analyses
PLoS ONE
Multidisciplinary
Cancer Patients Treated With Sunitinib or Sorafenib Have Sufficient Antibody and Cellular Immune Responses to Warrant Influenza Vaccination
Clinical Cancer Research
Cancer Research
Oncology
Thyroid Dysfunction in Patients With Suspected or Documented Supraventricular Tachyarrhythmia
International Journal of Arrhythmia
A Phase I, Open-Label Study of Trebananib Combined With Sorafenib or Sunitinib in Patients With Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Renal Dysfunction in Patients With Radioactive Iodine-Refractory Thyroid Cancer Treated With Tyrosine Kinase Inhibitors
Medicine
Medicine
Clinicopathological Features Predict Outcomes in Patients With Radioiodine‐Refractory Differentiated Thyroid Cancer Treated With Sorafenib: A Real‐World Study
Oncologist
Cancer Research
Medicine
Oncology
Early Decline in Serum Phospho-Cse1l Levels in Vemurafenib/Sunitinib-Treated Melanoma and Sorafenib/Lapatinib-Treated Colorectal Tumor Xenografts
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Reversible Myocardial Dysfunction in a Young Woman With Metastatic Renal Cell Carcinoma Treated With Sunitinib
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
